Skip to content

Clinical trials

Terminated Rhabdomyosarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rhabdomyosarcoma Status: Terminated Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20082
20131
20162
20172
20181
20191
20201
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Masonic Cancer Center, University of Minnesota2
National Cancer Institute (NCI)2
AeRang Kim1
Bayer1
Bristol-Myers Squibb1
City of Hope Medical Center1
Dana-Farber Cancer Institute1
Iovance Biotherapeutics, Inc.1
M.D. Anderson Cancer Center1
Mayo Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rhabdomyosarcoma17
Neuroblastoma11
Sarcoma, Ewing9
Sarcoma8
Osteosarcoma6
Medulloblastoma5
Neoplasms5
Wilms Tumor5
Brain Neoplasms4
Desmoplastic Small Round Cell Tumor4

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.